FDA Identifies Recall of B. Braun Medical Pump System as Most Serious

FDA Identifies Recall of B. Braun Medical Pump System as Most Serious
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly
|Updated:
0:00

The U.S. Food and Drug Administration (FDA) on Friday said it had identified the recall of B. Braun Medical Inc’s medicine-delivering pump system as most serious.

The Pennsylvania-based company had recalled some models of its Infusomat Space Volumetric infusion pump system in September due to faulty occlusion alarms, which may cause the pump to stop the delivery of medications pre-emptively or cause interruption.